Showing results (191-200 of 225) with videos related to

Sort By:
Pageof 23
Oncology Reports|November 5, 2015
Time-staggered inhibition of JNK effectively sensitizes chemoresistant ovarian cancer cells to cisplatin and paclitaxelManabu Seino, Masashi Okada, Hirotsugu Sakaki, et al.
Anticancer Research|December 6, 2015
GSKJ4, A Selective Jumonji H3K27 Demethylase Inhibitor, Effectively Targets Ovarian Cancer Stem CellsHirotsugu Sakaki, Masashi Okada, Kenta Kuramoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 8, 2014
[Long-term response to eribulin in patients with metastatic breast cancer-report of 2 cases]Yukiko Hara, Kenichi Sakurai, Saki Nagashima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 26, 2017
[Clinical Evaluation of Immunosuppressive Acidic Protein in the Serum of Patients with Inflammatory Breast Recurrence]Hironori Goto, Kenichi Sakurai, Shigeru Fujisaki, et al.
Brain Research|November 12, 2002
Neuropilin-2 is overexpressed in the rat brain after limbic seizuresShuichi Shimakawa, Shuhei Suzuki, Ryohei Miyamoto, et al.
In Vivo (Athens, Greece)|February 26, 2025
Pancreatic Mixed Acinar-neuroendocrine Carcinoma in a Patient With a Germline <i>PTEN</i> Variant: A Case Report and Genomic Literature ReviewYosuke Saito, Shuhei Suzuki, Tomomi Sanomachi, et al.
Anticancer Research|October 28, 2025
The MDM4 Inhibitor CEP-1347 Activates Wild-type p53 in Ovarian Clear Cell Carcinoma Cells and Potently Inhibits their GrowthYasufumi Ito, Kazuki Nakamura, Yurika Nakagawa-Saito, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 27, 2012
[A case of combined noninvasive ductal and lobular carcinoma]Saki Nagashima, Kenichi Sakurai, Shuhei Suzuki, et al.
Pharmaceuticals (Basel, Switzerland)|February 27, 2026
Genomic Landscape and Therapeutic Implications of Metaplastic Breast Carcinoma: Insights from a Nationwide Database Including Diagnostic MimickersShuhei Suzuki, Manabu Seino, Hidenori Sato, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|January 15, 2019
FOLFIRINOX for locally advanced pancreatic cancer: Results and prognostic factors of subset analysis from a nation-wide multicenter observational study in JapanIppei Matsumoto, Keiko Kamei, Katsuhiro Omae, et al.
Pageof 23